Table 3

Data on asthma-related medication use (during the study period)

Healthcare utilisation (N, IQR)
Mean (SD)
Intervention groupControl group
12 months before study period12 months after study period12 months before study period12 months after study period
SABA prescriptions3 (2,6)
3.92 (3.48)
3 (1,6)
4.00 (3.72)
3 (2,5)
4.0 (3.89)
4 (2,6)
4.39 (3.81)
ICS prescriptions5 (2,11)
6.72 (4.92)
4 (3,10)
6.15 (4.21)
6 (4,10)
7.41 (5.45)
6 (4,10)
7.34 (5.37)
Oral steroids prescriptions0 (0,0)
0.31 (0.80)
0 (0,0)
0.36 (0.94)
0 (0,0)
0.43 (1.07)
0 (0,0)
0.23 (0.71)
Antibiotic prescriptions0 (0,0)
0.33 (0.87)
0 (0,0)
0.28 (0.60)
0 (0,0)
0.52 (1.45)
0 (0,1)
0.16 (0.48)
  • ICS, Inhaled corticosteroids; SABA, Short-Acting Beta Agonist.